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Figure 3. Cytokine proﬁles from co-culture cultured with or without Triamcinolone cytokine proﬁle day 11).
alone (Fig. 1). Addition of Triamcinolone to the co-culture inhibited these
catabolic effects of synovial tissue on cartilage on GAG content (Fig. 2).
Cytokine proﬁles from the culture medium showed that both tissues
secreted cytokines. In cartilage cultured alone some cytokine that are
normally present in synovial ﬂuid of OA patients were not detected in the
medium. In the co-culture of cartilage and synovial tissue most cytokines
were present, indicating that for mimicking the osteoarthritic environment
both tissues are required. Addition of Triamcinolone decreased the amount
of cytokines released by the cartilage as well as the cytokines from the
synovial tissue (Fig. 3).
Conclusions: From the present data, we conclude that it is possible to
culture synovial tissue explants for at least 21 days. A co-culture with
synovial tissue explants enhances GAG release by the cartilage explants,
indicating the catabolic environment that is present in OA is mimicked
more closely in co-culture than in single explant culture. We demonstrate
the possibility to modulate this breakdown on both cartilage as synovial
tissue level by adding Triamcinolone. This study indicates the applicability
of this co-culture model to study the interaction between cartilage and
synovial tissue. Furthermore this model can be used for screening new
modulators of cartilage degeneration in OA.
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Purpose: Osteoarthritis (OA) features an imbalance of anabolic and
catabolic processes, ultimately resulting in loss of function and destruction
of cartilage. The major proteoglycan of articular cartilage, aggrecan, pro-
vides impact absorption and load bearing properties to the tissue. In OA,
ADAMTS-4 and ADAMTS-5 are key enzymes responsible for the degradation
of aggrecan. We have previously demonstrated that oral treatment with
an Aggrecanase Selective Inhibitor (ASI) in a rat model of joint injury/OA
is chondroprotective. Cytokine-induced bovine articular cartilage explants
are a common in vitro model of cartilage degradation, whereas in vitro
rat cartilage explant assays have not been extensively described. This
study investigated whether rat articular cartilage can be induced to release
aggrecan in response to catabolic stimuli, and whether the induction can
be attenuated by treatment with ASI.
Methods: Individual femoral head cartilage explants from approximately
3-week old male Lewis rats were cultured in 96-well plates. Treatments of
six wells per group consisted of a variety of cytokines or all-trans retinoic
acid (RA), +/- ASI (dose ranging between ∼80-5200nM) were cultured for
3 days with daily media exchange. Residual explants were digested with
1mg/ml proteinase K and aggrecan sGAG release was determined by assay-
ing culture media and cartilage extracts using DMMB. sGAG release was
normalized per cartilage weight and as a percentage of total sGAG per well.
Aggrecan cleavage by aggrecanases was measured by 374ARGN-aggrecan
ELISA as previously described. Relative cellular activity was determined
using a lactate colorimetric assay.
Results: Initial studies compared a number of induction conditions to iden-
tify a treatment that resulted in the greatest release of sGAG and 374ARGN
neoepitope in rat hip cartilage explant culture. Human TNF-α (100ng/ml),
IL-1α +/- OSM (both 10ng/ml) as well as mouse IL-1α and β (10ng/ml) failed
to signiﬁcantly induce sGAG release. Treatment with rat IL-1α and β and
human IL-1β (all 10ng/ml) resulted in an induction window of sGAG release
of 2× over background. The greatest induction by day 3 was generated
with 1 or 10μM RA resulting in ∼3× above background sGAG and 10-30×
374ARGN neoepitope. Lactate levels in conditioned media indicated that all
treatments were well tolerated as cellular activity was within 85% of the
media group. Treatment of explants with 1μM RA in the presence of ASI
resulted in dose-dependent inhibition of both sGAG and ARGN-aggrecan
release, demonstrating that sGAG release is aggrecanase-mediated, as in
bovine explant culture systems.
Conclusions: Similar to previously established bovine models, rat articular
cartilage can be induced to catabolize aggrecan in an aggrecanase-
dependent process, which can be prevented by treatment with an ag-
grecanase inhibitor. Since relative differences in ADAMTS-4 or ADAMTS-5
activities may exist between species, this assay will be useful as a tool
for pre-screening and selection of compounds for evaluation in rat in vivo
models.
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Purpose: Joint immobilization is a useful and commonly performed
treatment modality in orthopedics, however, it also causes unfavorable
outcomes such as joint contracture, periarticular osteoporosis, and cartilage
degeneration. Once joint contracture is established, it is extremely diﬃcult
to regain a full range of motion (ROM) with vigorous and extensive rehabil-
itation, or even with surgical treatment. Joint contracture is classiﬁed into
two types according to its etiology: arthrogenic (bone, cartilage, synovial
membrane, capsule, and ligaments) and myogenic (muscle, tendon, and
fascia). Some investigators insisted on an importance of the myogenic
components, whereas others did on the arthrogenic ones. Among the
arthrogenic components, capsular stiffness might contribute more to joint
contracture than the other ones. In our previous study, ROM after total
extra-articular myotomies was increased after the capsular release, which
indicated the capsule was one of the main causes of joint contracture.
Determination of the expression levels of structural collagens (collagen
types I and III), and ﬁbrogenetic factors, such as connective tissue growth
factor (CTGF) and transforming growth factor-β1 (TGF-β1) are a key to un-
derstand the elastic changes of the capsule. The purpose of this study was
to elucidate expression patterns of the capsule after joint immobilization
in a rat knee ﬂexion contracture model by multidirectional approach.
Methods: Unilateral knee joints of adult male Sprague-Dawley rats (body
weight, 380-400 g) were rigidly immobilized at 150° of ﬂexion with a
plate and screws for various periods (3 days, 1, 2, 4, 8, and 16 weeks).
Sham-operated animals had holes drilled in the femur and tibia with
screws inserted without a plate. The immobilized animals and the sham-
operated animals made up the immobilized group and the control group,
respectively. Five-μm sections at the medial midcondylar region in sagittal
plane were obtained for in situ hybridization (ISH) and immunohistochem-
istry (IHC). The capsules, without tendons, ligaments, and muscles, were
obtained with a surgical knife for quantitative PCR (qPCR) and Western
blotting (WB). Collagen types I and III were evaluated by ISH, qPCR, IHC,and
WB. CTGF and TGF-β1 were investigated by ISH and IHC.
Results: Expressions of collagen types I and III were decreased after immo-
